The first-ever international scientific congress L.UCA.RRE will take place on November 25, 2023 at the Hotel Aston la Scala in Nice under the patronage of Professor Jean-Pierre Gérard, President of the Antoine Lacassagne Centre. The aim of this event is to take stock of scientific advances in the treatment of rectal cancer.
The L.UCA.RRE Congress is supported by a number of renowned partners, including but not limited to: There European Society of Radiotherapy and Oncology (ESTRO), the French Society of Oncological Radiotherapy (SFERO), the National Cancer Institute, University cancerfrom the University of Côte d’Azur… Experts from will take part Brazil, the United States, Canada, Poland, Germany, Denmark, the Netherlands and the United Kingdom.
The context of this congress: the progress of research on rectal preservation in the treatment of rectal cancer
If curing these cancers usually requires major surgery that results in significant impairment of rectal function after treatment, nNew methods that preserve rectal function could well replace it in the long term. The Antoine Lacassagne Center has stood out in this new dynamic, in particular through an international project on the subject that it has carried out as a pilot. published in the renowned journal Lancet. This solution is now recommended and demonstrated by several French companiesmajor change in clinical practice in the detection of rectal cancer. A transformation largely driven by the Antoine Lacassagne Center!
There are several methods of rectal preservation during treatment. The aim of this congress is therefore to bring them together renowned international experts Dive into the topic in a single day to discuss these methods and establish new scientific consensuses.
The objectives and program of the L.UCA.RRE Congress
Chemotherapies, local excision surgery, intracavitary radiotherapy… the participating experts will try to determine the future of good practices in rectal oncology. during a Dens programe. With l’Gustave Roussy Institutethe center presents a large series of phase III clinical trials during this congress to evaluate and compare the therapeutic benefits of the various common solutions. This The sessions last 30 minutes each with question/answer periods and are preceded by a panel discussion with scientific conferences. This is the first time that current results from all of these randomized trials are presented simultaneously. This confrontation should therefore be possible significant progress in this area!
Scientists should do it then a second point about the progress of these new methods in a year in Sao Paulo, a pilot city for 10 years for conservative treatments of the rectum, in particular with the biannual FICARE Congress. If this dynamic of international cooperation continues as it should in 2025, Nice should welcome the second L.UCA.RRE congress and thus confirm Pioneering role in this strategy of “therapeutic de-escalation.”
This Riviera dynamic makes it possible little by little Patients in the PACA region are expected to benefit from these state-of-the-art, “conservative” treatments at the region’s various expert centers who are collaborating on this research.
